Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial – A Trans-Tasman Radiation Oncology Group study

Faculty Opinions recommendation of Randomised trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01) - a Trans-Tasman Radiation Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.740246443.793586289 ◽

2021 ◽

Author(s):

Melvin Chua

Keyword(s):

Radiation Oncology ◽

Oropharyngeal Cancer ◽

Randomised Trial ◽

Low Risk ◽

Oncology Group ◽

Oncology Group Study ◽

Weekly Cisplatin

Faculty Opinions recommendation of Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.740246443.793590386 ◽

2021 ◽

Author(s):

Sandra Nuyts ◽

Heleen Bollen

Keyword(s):

Radiation Therapy ◽

Randomized Trial ◽

Radiation Oncology ◽

Oropharyngeal Cancer ◽

Low Risk ◽

Oncology Group ◽

Oncology Group Study ◽

Weekly Cisplatin

Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2021.04.015 ◽

2021 ◽

Author(s):

Danny Rischin ◽

Madeleine King ◽

Lizbeth Kenny ◽

Sandro Porceddu ◽

Christopher Wratten ◽

...

Keyword(s):

Radiation Therapy ◽

Randomized Trial ◽

Radiation Oncology ◽

Oropharyngeal Cancer ◽

Low Risk ◽

Oncology Group ◽

Oncology Group Study ◽

Weekly Cisplatin

The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

International Journal of Cancer ◽

10.1002/ijc.30770 ◽

2017 ◽

Vol 141 (3) ◽

pp. 594-603 ◽

Cited By ~ 42

Author(s):

Panagiotis Balermpas ◽

Franz Rödel ◽

Mechthild Krause ◽

Annett Linge ◽

Fabian Lohaus ◽

...

Keyword(s):

Head And Neck Cancer ◽

Multicentre Study ◽

Human Papilloma Virus ◽

Head And Neck ◽

Neck Cancer ◽

Radiation Oncology ◽

Adjuvant Chemoradiotherapy ◽

Oncology Group ◽

Papilloma Virus ◽

Re: Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03 (Journal of Medical Imaging and Radiation Oncology 62 (2018) 412-419)

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/1754-9485.12792 ◽

2018 ◽

Vol 62 (5) ◽

pp. 671-671

Author(s):

Jonathan Pincus

Keyword(s):

Medical Imaging ◽

Cell Carcinoma ◽

Merkel Cell Carcinoma ◽

Radiation Oncology ◽

Fdg Pet ◽

Prospective Analysis ◽

Merkel Cell ◽

Oncology Group ◽

Oncology Group Study ◽

Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma

Journal of Medical Imaging and Radiation Oncology ◽

10.1111/1754-9485.12752 ◽

2018 ◽

Vol 62 (5) ◽

pp. 668-670

Author(s):

Nirdosh K Gogna ◽

Gillian Duchesne ◽

Peter O'Brien ◽

Nigel Spry ◽

Sandra Turner ◽

...

Keyword(s):

Cancer Research ◽

Bladder Cancer ◽

Radiation Oncology ◽

Moral Dilemma ◽

Phase Iii ◽

Oncology Group ◽

Muscle Invasive Bladder Cancer ◽

Cancer Trial ◽

Muscle Invasive

A multi-institutional study of bladder-preserving therapy for stage □ to □ bladder cancer: A Korean radiation oncology group study (KROG 14-16)

European Urology Supplements ◽

10.1016/s1569-9056(16)30488-2 ◽

2016 ◽

Vol 15 (13) ◽

pp. e1717-e1718

Author(s):

S.J. Byun ◽

J.H. Kim ◽

W. Park ◽

K.H. Cho ◽

J.H. Cho ◽

...

Keyword(s):

Bladder Cancer ◽

Radiation Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)

Strahlentherapie und Onkologie ◽

10.1007/s00066-020-01660-6 ◽

2020 ◽

Vol 196 (11) ◽

pp. 1034-1043 ◽

Cited By ~ 1

Author(s):

Pervin Hurmuz ◽

Cem Onal ◽

Gokhan Ozyigit ◽

Sefik Igdem ◽

Banu Atalar ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Outcomes ◽

Radiation Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Psma Pet ◽

Pet Ct ◽

Turkish Society

HCP-13PATTERN OF CARE AND OUTCOME OF ANAPLASTIC OLIGODENDROGLIOMAAND OLIGOASTROCYTOMA IN A KOREAN POPULATION: THE KOREAN RADIATION ONCOLOGY GROUP STUDY 13-12

Neuro-Oncology ◽

10.1093/neuonc/nov216.13 ◽

2015 ◽

Vol 17 (suppl 5) ◽

pp. v104.1-v104

Author(s):

In Ah Kim ◽

Tosol Yu ◽

Hyun-Cheol Kang ◽

Do Hoon Lim ◽

Il Han Kim ◽

...

Keyword(s):

Radiation Oncology ◽

Korean Population ◽

Oncology Group ◽

Oncology Group Study ◽

Risk and response adapted treatment for early stage Hodgkin's lymphoma (ESHL): Preliminary results of an Australasian Leukaemia & Lymphoma Group/Trans-Tasman Radiation Oncology Group study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6531 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6531-6531 ◽

Cited By ~ 2

Author(s):

A. Wirth ◽

A. Grigg ◽

M. Wolf ◽

S. Davis ◽

M. Hertzberg ◽

...

Keyword(s):

Radiation Oncology ◽

Hodgkin’S Lymphoma ◽

Early Stage ◽

Hodgkin's Lymphoma ◽

Oncology Group ◽

Oncology Group Study ◽

Preliminary Results ◽